Show Summary Details
Page of

Neuropharmacotherapy 

Neuropharmacotherapy
Chapter:
Neuropharmacotherapy
Author(s):

Gretchen M. Brophy

, and Theresa Human

DOI:
10.1093/med/9780199375349.003.0019
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 04 April 2020

In the neurologically injured patient, it is extremely important to optimize and individualize pharmacotherapeutic strategies to improve patient outcomes. Therefore, understanding the pharmacology, pharmacokinetics, and pharmacodynamics of medications used in neurocritical care patients, as well as the impact of the acute illness and comorbid states on these characteristics, is essential. This chapter provides practical information on medications and treatment strategies commonly used in patients with neurological injuries, including recommendations to optimize therapeutic strategies and avoid unwanted adverse effects and drug interactions. Specific medications and treatment strategies discussed include hyperosmolar therapy with mannitol and hypertonic saline for management of intracranial pressure, anticonvulsant treatments for status epilepticus and refractory status epilepticus, reversal strategies for oral anticoagulant agents, , shivering control agents for use during therapeutic temperature management and induced hypothermia, and vasoactive therapies to maintain hemodynamic control. The pharmacology, pharmacokinetic and pharmacodynamic characteristics, and clinical pearls of these commonly used treatments in neurocritical care patients will also be highlighted.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.